121 related articles for article (PubMed ID: 33165094)
21. Malignant teratoid medulloepithelioma with retinoblastic and rhabdomyoblastic differentiation.
Earl JB; Minckler DS; Lee TC; Murphree AL
J AAPOS; 2013 Jun; 17(3):328-31. PubMed ID: 23791415
[TBL] [Abstract][Full Text] [Related]
22. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
[TBL] [Abstract][Full Text] [Related]
23. Better visualization of retinoblastoma metastases with Tc-99m sestamibi versus Tl-201.
Aktolun C; Bayhan H; Ozturk E
Clin Nucl Med; 1995 May; 20(5):446-8. PubMed ID: 7628151
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis distinguishes metastatic disease from second cancers in patients with retinoblastoma.
Racher H; Soliman S; Argiropoulos B; Chan HS; Gallie BL; Perrier R; Matevski D; Rushlow D; Piovesan B; Shaikh F; MacDonald H; Corson TW
Cancer Genet; 2016; 209(7-8):359-63. PubMed ID: 27318443
[TBL] [Abstract][Full Text] [Related]
25. PHOX2B is a reliable immunomarker in distinguishing peripheral neuroblastic tumours from CNS embryonal tumours.
Alexandrescu S; Paulson V; Dubuc A; Ligon A; Lidov HG
Histopathology; 2018 Sep; 73(3):483-491. PubMed ID: 29758594
[TBL] [Abstract][Full Text] [Related]
26. Demonstration of S-100 protein immunoreactivity in normal human retina and retinoblastoma.
Karim MM; Itoh H
Ophthalmologica; 1997; 211(6):351-3. PubMed ID: 9380352
[TBL] [Abstract][Full Text] [Related]
27. Using RB1 mutations to assess minimal residual disease in metastatic retinoblastoma.
Dimaras H; Rushlow D; Halliday W; Doyle JJ; Babyn P; Abella EM; Williams J; Héon E; Gallie BL; Chan HS
Transl Res; 2010 Aug; 156(2):91-7. PubMed ID: 20627193
[TBL] [Abstract][Full Text] [Related]
28. Retinoblastoma in an adult: case report and literature review.
Odashiro AN; Pereira PR; de Souza Filho JP; Cruess SR; Burnier MN
Can J Ophthalmol; 2005 Apr; 40(2):188-91. PubMed ID: 16049534
[No Abstract] [Full Text] [Related]
29. Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases.
Fanburg-Smith JC; Hengge M; Hengge UR; Smith JS; Miettinen M
Ann Diagn Pathol; 1998 Dec; 2(6):351-62. PubMed ID: 9930572
[TBL] [Abstract][Full Text] [Related]
30. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
[TBL] [Abstract][Full Text] [Related]
31. Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2003 Sep; 27(9):1183-96. PubMed ID: 12960802
[TBL] [Abstract][Full Text] [Related]
32. Is CRX protein a useful marker in differential diagnosis of tumors of the pineal region?
Manila A; Mariangela N; Libero L; Francesca G; Romana BF; Felice G
Pediatr Dev Pathol; 2014; 17(2):85-8. PubMed ID: 24555912
[TBL] [Abstract][Full Text] [Related]
33. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.
Ozdemir H; Tacyildiz N; Unal E; Yavuz G; Ugur H; Gunduz K
Pediatr Hematol Oncol; 2007; 24(3):221-31. PubMed ID: 17454793
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.
Sugita S; Hirano H; Kikuchi N; Kubo T; Asanuma H; Aoyama T; Emori M; Hasegawa T
Diagn Pathol; 2016 Aug; 11(1):75. PubMed ID: 27515856
[TBL] [Abstract][Full Text] [Related]
35. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
[TBL] [Abstract][Full Text] [Related]
36. Workup for metastatic retinoblastoma. A review of 261 patients.
Karcioglu ZA; al-Mesfer SA; Abboud E; Jabak MH; Mullaney PB
Ophthalmology; 1997 Feb; 104(2):307-12. PubMed ID: 9052637
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow aspirations and lumbar punctures in retinoblastoma at diagnosis: correlation with IRSS staging.
Bakhshi S; Meel R; Kashyap S; Sharma S
J Pediatr Hematol Oncol; 2011 Jul; 33(5):e182-5. PubMed ID: 21364467
[TBL] [Abstract][Full Text] [Related]
38. Expression of Fas ligand in retinoblastoma.
Krishnakumar S; Kandalam M; Mohan A; Iyer A; Venkatesan N; Biswas J; Shanmugam MP
Cancer; 2004 Oct; 101(7):1672-6. PubMed ID: 15378505
[TBL] [Abstract][Full Text] [Related]
39. The Utility of ERBB4 and RB1 Immunohistochemistry in Distinguishing Chromophobe Renal Cell Carcinoma From Renal Oncocytoma.
Sun T; Hutchinson L; Zhou AG; Liu Q; Cosar EF; St Cyr M; Ninteau N; Dresser K; Cheng L; Jiang Z; Cornejo KM
Int J Surg Pathol; 2020 May; 28(3):259-264. PubMed ID: 31640438
[No Abstract] [Full Text] [Related]
40. Metastatic retinoblastoma: single institution experience over two decades.
Cozza R; De Ioris MA; Ilari I; Devito R; Fidani P; De Sio L; Demelas F; Romanzo A; Donfrancesco A
Br J Ophthalmol; 2009 Sep; 93(9):1163-6. PubMed ID: 19556217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
